Table 2.

Baseline sample characteristics by osteoarthritis (OA) status and by progression status. All data are mean (SD), unless otherwise indicated.

Cross-sectional cohortWhole cohort (weighted N = 252.5)NCP (weighted N = 34.4)PRCP (weighted N = 120.1)ROA (weighted N = 98.0)p
  Age, yrs56.8 (10.4)49.5 (9.9)54.9 (9.4)61.6 (9.6)< 0.001
  Female (%)56.358.051.461.60.315
  BMI, kg/m226.5 (4.9)25.4 (4.3)26.0 (4.4)27.4 (5.5)0.017
  WOMAC pain (0–100)20.5 (17.8)20.6 (16.7)17.9 (18.1)23.6 (17.4)0.115
Longitudinal cohortWhole cohort (weighted N = 160.5)No Progression (weighted N = 136.1)Progression (weighted N = 24.4)p
  Age, yrs57.7 (10.1)56.9 (10.1)62.1 (9.3)0.021
  Female (%)53.952.859.80.527
  BMI, kg/m226.0 (4.2)26.0 (4.3)25.8 (3.6)0.826
  WOMAC pain (0–100)19.6 (16.8)19.1 (17.0)22.6 (16.2)0.344
  Followup time, yrs; range3.3 (0.6); 2.5–5.13.4 (0.6); 2.5–5.13.2 (0.4); 2.9–5.10.387
  • P value for percentage female is based on chi-square test; other p values based on 1-way ANOVA. BMI: body mass index; WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index; NCP: no cartilage pathology; PRCP: preradiographic cartilage pathology; ROA: radiographic OA.